Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers

COVID-19 (coronavirus disease 2019) vaccines induce immunity through different mechanisms. The aim of this study is to compare the titers of specific antibodies in subjects vaccinated with either the Pfizer-BioNTech COVID-19 vaccine or the Sinopharm vaccine. This prospective observational cohort inc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rami Alqassieh, Aiman Suleiman, Sami Abu-Halaweh, Abeer Santarisi, Omar Shatnawi, Lara Shdaifat, Amjed Tarifi, Mohammad Al-Tamimi, Abdel-Ellah Al-Shudifat, Heba Alsmadi, Ahmed Al Sharqawi, Hadeel Alnawaiseh, Yara Anasweh, Farah Abo Domaidah, Haneen Abu Jaber, Mohammad Rashid Al-Zarir, Isam Bsisu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
vaccine
Pfizer-BioNTech
Sinopharm
antibody
titers
Medicine
R
Acceso en línea:https://doaj.org/article/f8f682652ba740478ffafd39c31b17c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares